To address this, we quantified LMNTD2-AS1 expression using qRT-PCR in both tumor tissues and adjacent non-tumor peritumoral tissues, observing a significant upregulation of LMNTD2-AS1 in tumor samples compared with their normal counterparts. The gene discussed is LMNTD2; the disease is neoplasm.